Shaila Misri1, Andrea B Eng, Jasmin Abizadeh, Ekin Blackwell, Alicia Spidel, Tim F Oberlander. 1. Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada; Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada; Reproductive Mental Health Program, BC Women's Hospital, Vancouver, British Columbia, Canada.
Abstract
PURPOSE: To identify specific quantitative and qualitative factors that govern the decision to adhere or decline antidepressant medication in antenatal women with moderate-to-severe mood and anxiety disorders. METHODS: Fifty women (30 adherers, 20 decliners) were recruited between 18 and 34 weeks gestation in a tertiary care clinic for perinatal mothers. They were prospectively monitored 4 weeks apart up to 1-month postpartum on the: Hamilton Anxiety Scale, Hamilton Depression Scale, Mood Disorders Insight Scale, Antidepressant Compliance Questionnaire, Penn State Worry Questionnaire, and NEO Personality Inventory. Qualitative interviews were conducted at baseline. Hierarchical linear modeling determined illness trajectories of the two groups. RESULTS: Significantly different course of illness was observed in adherers versus decliners. Adherers had healthier attitudes toward depression and compliance with medication (P < .005). Decliners had less illness insight (P < .001) and cited fear of fetal exposure, and thought medication was unwarranted. CONCLUSIONS: Pregnant women experienced significantly divergent illness trajectories depending on if they accepted antidepressant medication therapy for their illness. Risk perception, attitudes, and illness insight impacted decisions surrounding adherence and decline.
PURPOSE: To identify specific quantitative and qualitative factors that govern the decision to adhere or decline antidepressant medication in antenatal women with moderate-to-severe mood and anxiety disorders. METHODS: Fifty women (30 adherers, 20 decliners) were recruited between 18 and 34 weeks gestation in a tertiary care clinic for perinatal mothers. They were prospectively monitored 4 weeks apart up to 1-month postpartum on the: Hamilton Anxiety Scale, Hamilton Depression Scale, Mood Disorders Insight Scale, Antidepressant Compliance Questionnaire, Penn State Worry Questionnaire, and NEO Personality Inventory. Qualitative interviews were conducted at baseline. Hierarchical linear modeling determined illness trajectories of the two groups. RESULTS: Significantly different course of illness was observed in adherers versus decliners. Adherers had healthier attitudes toward depression and compliance with medication (P < .005). Decliners had less illness insight (P < .001) and cited fear of fetal exposure, and thought medication was unwarranted. CONCLUSIONS: Pregnant women experienced significantly divergent illness trajectories depending on if they accepted antidepressant medication therapy for their illness. Risk perception, attitudes, and illness insight impacted decisions surrounding adherence and decline.
Authors: Mary Kimmel; Edward Hess; Patricia S Roy; Jennifer Teitelbaum Palmer; Samantha Meltzer-Brody; Jennifer M Meuchel; Emily Bost-Baxter; Jennifer L Payne Journal: Arch Womens Ment Health Date: 2014-07-01 Impact factor: 3.633
Authors: Gustaf Rejnö; Cecilia Lundholm; Sara Öberg; Paul Lichtenstein; Henrik Larsson; Brian D'Onofrio; Kjell Larsson; Sissel Saltvedt; Bronwyn K Brew; Catarina Almqvist Journal: Sci Rep Date: 2019-09-11 Impact factor: 4.379
Authors: Ludvig D Bjørndal; Fatima Tauqeer; Kristin S Heiervang; Hanne K Clausen; Kristine Heitmann; Angela Lupattelli Journal: BMJ Open Date: 2022-09-30 Impact factor: 3.006
Authors: Anick Bérard; Andrea Gaedigk; Odile Sheehy; Christina Chambers; Mark Roth; Pina Bozzo; Diana Johnson; Kelly Kao; Sharon Lavigne; Lori Wolfe; Dee Quinn; Kristen Dieter; Jin-Ping Zhao Journal: Front Pharmacol Date: 2017-07-17 Impact factor: 5.810